Stock DNA
Pharmaceuticals & Biotechnology
USD 12 Million (Micro Cap)
NA
0.00%
0.04
-999,999.00%
0.14
Total Returns (Price + Dividend) 
OSR Holdings, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
Is OSR Holdings, Inc. technically bullish or bearish?
As of 1 October 2023, the technical stance for OSR Holdings, Inc. is bearish overall, with some mixed signals. The weekly MACD is mildly bullish, but the monthly MACD shows no signal. The RSI indicates a bullish stance on the monthly timeframe, while the weekly RSI has no signal. However, the moving averages are bearish on the daily timeframe, and both the KST and OBV are bearish on the weekly timeframe. Additionally, Bollinger Bands show a mildly bearish trend weekly and a bearish trend monthly. In terms of performance, the stock has returned 18.25% over the past week and 28.32% over the past month, significantly outperforming the S&P 500, which returned 1.05% and 2.33% respectively. However, year-to-date and one-year returns are notably poor at -93.59% and -93.38%, compared to the S&P 500's returns of 12.22% and 17.14%....
Read MoreIs OSR Holdings, Inc. overvalued or undervalued?
As of 9 August 2024, the valuation grade for OSR Holdings, Inc. has moved from does not qualify to risky, indicating a deterioration in its investment appeal. The company appears to be overvalued, particularly given its P/E ratio of -1.1666 and EV to EBITDA of -2.4983, which are significantly below industry norms. The absence of a PEG ratio further complicates the valuation picture, suggesting that the company is not generating expected growth relative to its price. In comparison to its peers, OSR Holdings, Inc. is underperforming, with its valuation metrics indicating a lack of financial health. For instance, its P/E ratio is notably worse than the industry average, which typically reflects more robust financial performance. Over the past year, OSR Holdings has seen a staggering decline of 93.38% in stock price, while the S&P 500 has returned 17.14%, reinforcing the notion that the stock is not only overv...
Read More Announcements 
Corporate Actions 
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot
Shareholding Compare (%holding) 
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
QoQ Growth in quarter ended Jun 2025 is 37.50% vs 0.00% in Mar 2025
QoQ Growth in quarter ended Jun 2025 is 54.39% vs -470.00% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023
YoY Growth in year ended Dec 2024 is -700.00% vs 0.00% in Dec 2023






